Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Many transgender men on testosterone therapy experience hair loss.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Testosterone therapy in transgender men can cause acne.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Finasteride effectively treats hair loss in transgender men with few side effects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Feminizing hormone therapy increases kidney filtration rate.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.